← Zepp Health Corp
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net loss | $23.9m | $167.1m | $336.3m | $573.4m | $229.7m | $137.0m | ($289.0m) | ($212.6m) | ($75.8m) | ($40.1m) | — | |
| Net Income (Loss) Attributable to Parent | $23.9m |
$25.8m
+7.62%
|
$49.5m
+91.91%
|
$82.6m
+67.06%
|
$35.1m
-57.57%
|
$21.6m
-38.32%
|
($41.8m)
-293.31%
|
($29.9m)
+28.53%
|
($75.7m)
-153.48%
|
($40.1m)
+47.09%
|
— | |
| Net Income (Loss) Available to Common Stockholders, Basic | ($12.1m) |
$7.1m
+158.46%
|
$16.5m
+132.89%
|
$82.3m
+398.46%
|
$35.1m
-57.39%
|
$21.6m
-38.32%
|
($41.8m)
-293.31%
|
($29.9m)
+28.53%
|
($75.7m)
-153.48%
|
($40.1m)
+47.09%
|
— | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $23.9m | $25.7m | $48.9m | $82.4m | $35.2m | $21.5m | ($41.9m) | ($29.9m) | ($75.8m) | ($40.1m) | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | ($90k) | ($542k) | ($262k) | $146k | ($134k) | ($100k) | ($65k) | ($75k) | — | — | |
| Depreciation, Depletion and Amortization | — | — | $6.2m | $17.2m | $4.2m | $8.1m | $8.5m | $7.7m | $5.0m | $4.5m | $4.5m | |
| Amortization of Intangible Assets | — | $27k | $65k | $1.1m | $12.2m | $16.8m | $17.2m | $17.7m | $2.4m | $2.8m | — | |
| Depreciation | $2.4m | $544k | $840k | $1.4m | $14.9m | $35.1m | $41.4m | $36.8m | $2.6m | $1.7m | $1.7m | |
| Deferred Income Tax Expense (Benefit) | ($18.5m) | ($2.9m) | ($4.8m) | ($27.8m) | ($11.1m) | ($20.8m) | ($66.3m) | ($18.7m) | $13.4m | $2.2m | $2.2m | |
| Deferred income taxes | ($18.5m) | ($19.0m) | ($32.9m) | ($27.8m) | ($10.4m) | ($18.7m) | ($65.2m) | ($18.7m) | $13.4m | $2.2m | $2.2m | |
| Share-based Payment Arrangement, Noncash Expense | $57.7m | $9.7m | $19.6m | $7.9m | $10.0m | $13.0m | $7.1m | $8.4m | $4.8m | $2.5m | $2.5m | |
| Share-based Payment Arrangement, Expense | — | — | — | $55.1m | $65.2m | $83.1m | $49.1m | $59.7m | $4.8m | $2.5m | $2.5m | |
| Share-based compensation | $57.7m | $62.8m | $134.7m | $55.1m | $65.2m | $83.1m | $49.1m | $59.7m | $4.8m | $2.5m | $2.5m | |
| Equity Method Investment, Other than Temporary Impairment | $0 | $0 | $4.1m | $218k | $0 | $0 | $0 | $2.3m | $0 | $0 | — | |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | — | — | $0 | $2.4m | $0 | $0 | $13.9m | $0 | $7.3m | $0 | — | |
| Goodwill, Impairment Loss | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.2m | |
| Impairment of Intangible Assets (Excluding Goodwill) | — | — | — | — | — | $0 | $0 | $8.0m | $0 | $0 | — | |
| Impairment of Intangible Assets, Finite-lived | — | — | — | — | — | — | $0 | $1.1m | $0 | $0 | — | |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | $0 | $0 | $0 | — | — | — | — | — | — | — | — | |
| Impairment loss from long-term investments | — | — | $7.6m | $2.6m | — | — | $13.9m | $2.3m | $8.2m | $1.2m | — | |
| Impairment loss from short-term investments | — | — | — | — | — | $320k | $0 | $0 | $1.9m | $1.0m | — | |
| Impairment loss from intangible assets | — | — | — | — | — | $0 | $0 | $8.0m | $0 | $0 | — | |
| Income (Loss) from Equity Method Investments | ($1.8m) | $431k | $254k | ($160k) | ($728k) | $6.4m | $2.6m | $1.2m | ($4.2m) | ($2.1m) | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | ($2.2m) | $2.0m | $3.8m | $18.7m | $20.1m | $37.6m | $21.1m | ($35.3m) | $5.1m | $8.3m | ($11.5m) | |
| Accounts Receivable, Credit Loss Expense (Reversal) | — | — | — | — | — | $128k | $95k | — | $1.6m | $7.5m | ($11.5m) | |
| Accounts receivable | $2.2m | ($13.2m) | ($26.1m) | ($130.0m) | ($131.2m) | ($239.9m) | ($145.7m) | $250.9m | ($5.1m) | ($8.3m) | ($11.5m) | |
| Increase (Decrease) in Inventories | $103.5m | $8.9m | $34.2m | $62.2m | $62.9m | $13.0m | ($27.2m) | ($51.8m) | ($5.6m) | $22.1m | ($22.1m) | |
| Inventory Write-down | $1.0m | $376k | $0 | $17.7m | $59.9m | $47.1m | — | — | — | — | — | |
| Provision for excess and obsolete inventories | — | $2.4m | $0 | $23.8m | $64.2m | $51.3m | $39.6m | $51.7m | $5.2m | $7.8m | — | |
| Inventories | ($103.5m) | ($57.6m) | ($234.9m) | ($433.0m) | ($410.7m) | ($83.1m) | $187.9m | $367.6m | $5.6m | ($22.1m) | ($22.1m) | |
| Increase (Decrease) in Accounts Payable | $272.0m | $27.9m | $51.8m | $134.4m | ($1.5m) | ($105.6m) | ($132.0m) | ($27.0m) | $14.8m | $28.3m | $28.3m | |
| Accounts payable | $272.0m | $181.6m | $356.3m | $935.8m | ($9.8m) | ($673.2m) | ($910.7m) | ($191.9m) | $14.8m | $28.3m | $28.3m | |
| Income tax payables | $21.7m | $972k | $32.4m | $13.8m | ($40.1m) | ($25.1m) | $119k | $4.3m | ($478k) | ($189k) | — | |
| Purchases of property and equipment, accrued but unpaid | $10.3m | $3.3m | $2.5m | $4.9m | $12.8m | $7.2m | $1.2m | $1.6m | $1.4m | $516k | ($784k) | |
| Accrued expenses and other current liabilities | $28.8m | $45.6m | $119.9m | $86.2m | ($149.4m) | $7.8m | ($60.3m) | $93.6m | ($6.0m) | ($4.0m) | — | |
| Prepaid expenses and other current assets | $6.7m | ($33.0m) | ($5.7m) | ($32.4m) | ($80.0m) | ($158.8m) | $210.8m | ($9.4m) | ($1.4m) | ($16.2m) | — | |
| Net Cash Provided by (Used in) Operating Activities | $17.3m |
$36.6m
+112.16%
|
$102.9m
+180.95%
|
$61.5m
-40.26%
|
$24.1m
-60.79%
|
($36.5m)
-251.30%
|
($114.2m)
-213.11%
|
$42.1m
+136.84%
|
($24.4m)
-157.98%
|
($25.7m)
-5.33%
|
($25.7m)
0.00%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $10.3m | $3.3m | $2.5m | $4.9m | $12.8m | $7.2m | $1.2m | $1.6m | $1.4m | $516k | ($784k) | |
| Gain (Loss) on Disposition of Property Plant Equipment | — | ($30k) | ($4k) | ($110k) | ($1.1m) | $48k | $277k | ($53k) | $56k | ($21k) | $2.1m | |
| Gain (Loss) on Investments | — | — | $1.1m | — | — | — | — | — | — | — | ($777k) | |
| Unrealized Gain (Loss) on Investments | — | — | — | — | — | — | $0 | $0 | — | — | ($76k) | |
| Gain from fair value change of long-term investments | — | — | ($7.9m) | — | ($12.3m) | — | ($51.8m) | ($1.2m) | ($2.0m) | ($76k) | — | |
| Realized gain from investments | — | ($2.4m) | ($261k) | ($1.8m) | — | ($13.5m) | ($597k) | ($777k) | — | — | — | |
| Disposal of short-term investments | — | $2.1m | — | $10.5m | — | — | $4.0m | $8.9m | $275k | — | — | |
| Purchase of long-term investments | ($62.9m) | ($23.6m) | ($109.9m) | ($180.9m) | ($82.2m) | ($1.1b) | ($12.7m) | ($2.0m) | ($7.0m) | — | — | |
| Disposal of long-term investments | — | $23.1m | — | $10.5m | — | $20.0m | $2.8m | $33.0m | $4.9m | $1.7m | — | |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | — | — | $4.1m | — | — | — | — | — | — | |
| Payments for (Proceeds from) Other Investing Activities | — | — | — | — | ($1k) | — | — | — | — | — | — | |
| Net Cash Provided by/(Used in) by Investing Activities | ($99.4m) | ($38.9m) | ($324.8m) | ($112.7m) | ($206.9m) | ($1.1b) | ($42.3m) | $54.7m | ($1.6m) | $1.5m | — | |
| Net Cash Provided by (Used in) Investing Activities | ($99.4m) | ($6.0m) | ($47.2m) | ($16.2m) | ($31.7m) | ($167.8m) | ($6.1m) | $7.7m | ($1.6m) | $1.5m | $1.5m | |
| Cash flows from financing activities: | ||||||||||||
| Debt and Equity Securities, Unrealized Gain (Loss) | — | — | — | — | $1.9m | — | $7.5m | $176k | $2.0m | $76k | — | |
| Bank borrowings received | $10.0m | $30.0m | $20.0m | — | $1.2b | $1.5b | $838.9m | $400.0m | $11.0m | $65.7m | — | |
| Repayment of bank borrowings | — | ($10.0m) | ($30.0m) | ($20.0m) | ($643.1m) | ($953.4m) | ($727.5m) | ($735.0m) | ($12.6m) | ($73.1m) | — | |
| Payments for Repurchase of Common Stock | — | — | $1.2m | — | — | $2.2m | $7.7m | $2.5m | $2.3m | $1.2m | — | |
| Payments of Ordinary Dividends, Common Stock | — | — | — | $1 | — | — | $6 | — | — | — | $0 | |
| Dividends Payable | — | — | — | — | — | — | — | $0 | — | — | — | |
| Net Cash (Used in)/Provided by Financing Activities | $10.0m |
$20.1m
+100.41%
|
$639.2m
+3081.69%
|
$25.6m
-95.99%
|
$564.7m
+2104.97%
|
$551.1m
-2.41%
|
$289.2m
-47.52%
|
($295.0m)
-202.02%
|
$477k
+100.16%
|
$24.8m
+5106.50%
|
— | |
| Net Cash Provided by (Used in) Financing Activities | $10.0m |
$3.1m
-69.20%
|
$93.0m
+2911.44%
|
$3.7m
-96.04%
|
$86.5m
+2252.88%
|
$86.5m
-0.07%
|
$41.9m
-51.52%
|
($41.6m)
-199.11%
|
$477k
+101.15%
|
$24.8m
+5106.50%
|
$24.8m
0.00%
|
|
| Net increase /(decrease) in cash and cash equivalents and restricted cash | ($72.1m) | $219.5m | $1.0b | $340.9m | $515.1m | ($750.6m) | ($540.7m) | $58.4m | ($25.5m) | $623k | — | |
| Cash and cash equivalents and restricted cash at beginning of the year | $153.2m | $369.5m | $1.5b | $1.8b | $2.3b | $1.5b | $973.3m | $997.3m | $110.7m | $112.9m | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $23.5m | $56.8m | $211.2m | $259.1m | $348.8m | $236.9m | $141.1m | $140.5m | $110.7m | $112.9m | $112.9m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $5.3m | ($488k) | $8.8m | $1.6m | ($6.6m) | ($2.4m) | — | — | — | — | $1.6m | |
| Restricted cash | — | — | — | — | — | — | $12.6m | $6.8m | $19.7m | $55.9m | — | |
| Effect of exchange rate changes | $5.3m | ($3.2m) | $60.4m | $11.3m | ($43.3m) | ($15.6m) | $4.5m | ($34.4m) | ($4.2m) | $1.6m | $1.6m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | $24k | $13k | — | — | — | $858k | — | — | — | — | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | $2.0m | $191k | $41k | $2.3m | $7.4m | $8.1m | $6.2m | $89k | $1.2m | — | |
| Noncash investing and financing activities: | ||||||||||||
| Additional Financial Items | ||||||||||||
| Deconsolidation, Gain (Loss), Amount | — | — | — | — | $8.7m | — | — | — | — | — | — | |
| General and Administrative Expense | $102.6m | $17.7m | $31.1m | $35.7m | $40.1m | $40.5m | $34.2m | $26.6m | $24.9m | $29.3m | — | |
| Goodwill | $0 | $911k | $862k | $852k | $9.6m | $9.6m | $9.6m | $9.6m | $9.6m | $9.6m | $2.2m | |
| Income Tax Expense (Benefit) | $3.1m | $4.2m | $7.6m | $11.2m | $4.8m | $1.7m | ($9.6m) | ($2.2m) | $13.7m | $2.5m | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $5.6m | $5.7m | — | |
| Operating Expenses | $262.8m | $48.1m | $83.4m | $123.7m | $177.5m | $190.1m | $175.9m | $121.8m | $117.5m | $128.4m | — | |
| Realized Investment Gains (Losses) | — | $365k | $38k | $262k | — | $2.1m | $87k | $109k | — | — | — | |
| Non-cash lease expenses | — | — | — | $27.7m | $48.2m | $41.5m | $40.6m | $34.3m | $1.5m | $1.3m | — | |
| Allowance for doubtful accounts | — | — | — | — | — | $814k | $652k | — | $1.6m | $7.5m | — | |
| Amounts due from related parties | ($287.7m) | ($109.8m) | ($45.1m) | ($771.0m) | $583.5m | $544.6m | $166.2m | $48.4m | $5.5m | ($3.2m) | — | |
| Other non-current assets | — | — | ($3.1m) | ($2.7m) | ($33.0m) | $8.6m | ($30.8m) | ($18.5m) | $4.5m | $333k | — | |
| Amounts due to related parties | — | ($281k) | $5.8m | $4.1m | ($3.6m) | $38.9m | ($9.1m) | ($16.3m) | ($998k) | ($1.9m) | — | |
| Notes payable | $2.7m | $2.6m | $13.7m | ($16.8m) | ($2.2m) | $103.8m | $42.4m | ($38.0m) | ($8.6m) | $11.6m | — | |
| Advance from customers | $5.9m | $4.3m | ($4.7m) | $38.9m | ($2.2m) | ($38.3m) | ($2.1m) | ($480k) | ($36k) | ($126k) | — | |
| Other non-current liabilities | — | $4.9m | $51.3m | $57.3m | $68.7m | ($10.1m) | ($12.5m) | ($160.7m) | ($129k) | $68k | — | |
| Purchase of intangible assets | ($1.2m) | ($88k) | ($52.0m) | ($11.8m) | ($1.2m) | ($7.0m) | ($1.8m) | ($587k) | ($87k) | ($268k) | — | |
| Disposal of intangible assets | — | — | — | — | — | — | — | $22.2m | $1.1m | $471k | — | |
| Loans provided to related parties | ($16.1m) | — | ($5.0m) | — | — | — | ($15.5m) | ($9.9m) | — | — | — | |
| Deconsolidation of a subsidiary and others | — | — | — | — | ($7.7m) | $20.0m | $60k | $2.8m | — | — | — | |
| Repurchase of ordinary shares | — | — | ($8.2m) | — | — | ($13.8m) | ($53.2m) | ($17.8m) | ($2.3m) | ($1.2m) | — | |
| Letter of credit factoring received | — | — | — | — | — | — | $310.3m | $57.2m | $5.1m | $131.5m | — | |
| Repayment of letter of credit factoring | — | — | — | — | — | — | — | ($58.6m) | ($62.7m) | ($97.0m) | — | |
| Purchase of non-controlling interest | — | — | — | — | — | — | — | — | ($705k) | ($1.1m) | — | |
| Cash and cash equivalents | $2k | — | — | — | — | — | $128.6m | $133.7m | $91.1m | $57.0m | $110.7m | |
| Income tax (receipt)/paid- Mainland China | $9.6m | $35.9m | $52.1m | $91.7m | $82.4m | $74.4m | $3.4m | ($1.7m) | $62k | $293k | — | |
| Receivable from the disposal of intangible assets | — | — | — | — | — | — | — | $19.7m | $1.7m | $1.2m | — | |
| Conversion from loan to long-term investment | — | $8.0m | — | — | — | — | — | $17.1m | — | — | — | |
| Payable/(Receivable) for repurchasing of ordinary shares | — | — | — | — | — | $8.0m | $129k | $418k | ($100k) | ($118k) | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.